We’re still waiting for the Supreme Court to issue its decision inAmgen v. Sanofi. But in the meantime, the Federal Circuit continues to provide insights into 35 U.S.C. § 112’s requirement to “enable” persons of skill in the art to “make and use” a claimed invention.